12:00 – 1:30 pm EST
Please click here to view the archived presentation.
The current climate for medical device investments and acquisitions requires thorough due diligence of potential acquisitions. New developments brought about by the America Invents Act, such as the medical device tax and patent changes, create hurdles for successful deals. In addition, these issues and other changing market dynamics have the potential to influence valuation of medical device firms.
Topics addressed on the webcast will include:
Hidden issues in the medical device tax—how to understand and conduct due diligence
How to integrate changes from the America Invents Act into intellectual property due diligence
What drives high valuations? What do medical device “consolidators” look for in an acquisition?
Laurence M. Barr, Senior Vice President, Business Development, Kinsella Group
Robert H. Underwood, Ph.D., Partner, McDermott Will & Emery LLP
Kristian A. Werling, Partner, McDermott Will & Emery LLP
For more information, please contact McDermott Events.
CLE credit for the live presentation of this program is pending in the following states: California, Illinois and New York. A Uniform Certificate of Attendance will be made available to participants requesting CLE credit in all other states. Credit shall be awarded only for attendance of the entire webcast; no partial credit shall be awarded for attending a portion of the webcast. Please note that in accordance with applicable state MCLE rules regarding attendance validation, each attendee seeking credit must log in to the webcast individually. Credit will not be granted for multiple attendees using one log in. Please be advised that CLE credit will not be approved for on demand/recorded viewings of this program in the states listed above. Attendees seeking credit in other states should consult their state CLE accrediting agency to determine whether self-study credit can be earned for on demand/recorded viewing of this program.